Bai, D.-P., Zhang, X.-F., Zhang, G.-L., Huang, Y.-F., & Gurunathan, S. (2017). Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells. International journal of nanomedicine, 12, 6521.
Bai, L., & Zhu, W.-G. (2006). p53: structure, function and therapeutic applications. J Cancer Mol, 2(4), 141-153.
Balasubramanyam, A., Sailaja, N., Mahboob, M., Rahman, M., Hussain, S. M., & Grover, P. (2009). In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Mutagenesis, 24(3), 245-251.
Barik, B. K., & Mishra, M. (2019). Nanoparticles as a potential teratogen: a lesson learnt from fruit fly. Nanotoxicology, 13(2), 258-284.
Bashiri Dezfouli, A., Salar-Amoli, J., Yazdi, M., Ali-Esfahani, T., & Barin, A (2017). Evaluation of the Antioxidant Activities and Cytotoxicities of Selected Medicinal Herbs Using Human Hepatoma Cell Line (Hepg2). Iranian Journal of Toxicology, 11(6), 13-20.
Bashiri Dezfouli, A., Salar‐Amoli, J., Pourfathollah, A. A., Yazdi, M., Nikougoftar‐Zarif, M., Khosravi, M., & Hassan, J. (2020). Doxorubicin‐induced senescence through NF‐κB affected by the age of mouse mesenchymal stem cells. Journal of cellular physiology, 235(3), 2336-2349.
Bergh, J. (1999). Clinical studies of p53 in treatment and benefit of breast cancer patients. Endocrine-related cancer, 6(1), 51-59.
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009). Awakening guardian angels: drugging the p53 pathway. Nature Reviews Cancer, 9(12), 862-873.
Buhrmann, C., Yazdi, M., Dezfouli, A. B., Sahraneshin, F. S., Ebrahimi, S. M., Ghaffari, S. H., et al. (2020). Significant decrease in the viability and tumor stem cell marker expression in tumor cell lines treated with curcumin. Journal of Herbal Medicine, 100339.
Buzea, C., Pacheco, I. I., & Robbie, K. (2007). Nanomaterials and nanoparticles: sources and toxicity. Biointerphases, 2(4), MR17-MR71.
Demir, E., Burgucu, D., Turna, F., Aksakal, S., & Kaya, B. (2013). Determination of TiO2, ZrO2, and Al2O3 nanoparticles on genotoxic responses in human peripheral blood lymphocytes and cultured embyronic kidney cells. Journal of Toxicology and Environmental Health, Part A, 76(16), 990-1002.
Dey, S., Bakthavatchalu, V., Tseng, M. T., Wu, P., Florence, R. L., Grulke, E. A., et al. (2008). Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al 2 O 3) nanoparticles in mouse skin epithelial cells. Carcinogenesis, 29(10), 1920-1929.
Dezfouli, A. B., Pourfathollah, A. A., Salar-Amoli, J., Khosravi, M., Nikogoftar-Zarif, M., Yazdi, M., & Ali-Esfahani, T. (2017). Evaluation of age effects on doxorubicin-induced toxicity in mesenchymal stem cells. Medical journal of the Islamic Republic of Iran, 31, 98.
Dixon, K., & Kopras, E. (2004). Genetic alterations and DNA repair in human carcinogenesis. Paper presented at the Seminars in cancer biology.
Friedler, A., Veprintsev, D. B., Freund, S. M., Karoly, I., & Fersht, A. R. (2005). Modulation of binding of DNA to the C-terminal domain of p53 by acetylation. Structure, 13(4), 629-636.
Ghosh, M., Sinha, S., Jothiramajayam, M., Jana, A., Nag, A., & Mukherjee, A. (2016). Cyto-genotoxicity and oxidative stress induced by zinc oxide nanoparticle in human lymphocyte cells in vitro and Swiss albino male mice in vivo. Food and Chemical Toxicology, 97, 286-296.
Hainaut, P., Hernandez, T., Robinson, A., Rodriguez-Tome, P., Flores, T., Hollstein, M., et al. (1998). IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic acids research, 26(1), 205-213.
Ickrath, P., Wagner, M., Scherzad, A., Gehrke, T., Burghartz, M., Hagen, R. et al. (2017). Time-dependent toxic and genotoxic effects of zinc oxide nanoparticles after long-term and repetitive exposure to human mesenchymal stem cells. International journal of environmental research and public health, 14(12), 1590.
Jeng, H. A., & Swanson, J. (2006). Toxicity of metal oxide nanoparticles in mammalian cells. Journal of Environmental Science and Health Part A, 41(12), 2699-2711.
Keller, A. A., McFerran, S., Lazareva, A., & Suh, S. (2013). Global life cycle releases of engineered nanomaterials. Journal of nanoparticle research, 15(6), 1692.
Lewis, P., & Parry, J. (2004). In silico p53 mutation hotspots in lung cancer. Carcinogenesis, 25(7), 1099-1107.
Li, Z., Guo, D., Yin, X., Ding, S., Shen, M., Zhang, R. et al. (2020). Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C/Apaf-1/Caspase-9/Caspase-3 signaling pathway in vitro. Biomedicine & Pharmacotherapy, 122, 109712.
Madapura, H. S., Salamon, D., Wiman, K. G., Lain, S., Klein, G., Klein, E., & Nagy, N. (2012). p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP. Cell cycle, 11(24), 4563-4569.
Manke, A., Wang, L., & Rojanasakul, Y. (2013). Mechanisms of nanoparticle-induced oxidative stress and toxicity. BioMed research international, 2013: 942916.
McCormick, F. (2001). Cancer gene therapy: fringe or cutting edge? Nature Reviews Cancer, 1(2), 130-141.
Meulmeester, E., & Jochemsen, A. G. (2008). p53: a guide to apoptosis. Current cancer drug targets, 8(2), 87-97.
Nikolova, P. V., Wong, K. B., DeDecker, B., Henckel, J., & Fersht, A. R. (2000). Mechanism of rescue of common p53 cancer mutations by second‐site suppressor mutations. The EMBO Journal, 19(3), 370-378.
Parveen, S., Misra, R., & Sahoo, S. K. (2012). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine: Nanotechnology, Biology and Medicine, 8(2), 147-166.
Paskulin, D., Cunha-Filho, J., Souza, C., Bortolini, M., Hainaut, P., & Ashton-Prolla, P. (2012). TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure. Cell death & disease, 3(9), e392-e392.
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Human mutation, 28(6), 622-629.
Powell, B., Soong, R., Iacopetta, B., Seshadri, R., & Smith, D. R. (2000). Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clinical cancer research, 6(2), 443-451.
Radziun, E., Wilczyńska, J. D., Książek, I., Nowak, K., Anuszewska, E., Kunicki, A. et al. (2011). Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells. Toxicology in vitro, 25(8), 1694-1700.
Sengul, A. B., & Asmatulu, E. (2020). Toxicity of metal and metal oxide nanoparticles: a review. Environmental Chemistry Letters, 1-25.
Sliwinska, A., Kwiatkowski, D., Czarny, P., Milczarek, J., Toma, M., Korycinska, A. et al. (2015). Genotoxicity and cytotoxicity of ZnO and Al2O3 nanoparticles. Toxicology mechanisms and methods, 25(3), 176-183.
Taheri, S., Banaee, M., Haghi, B. N., & Mohiseni, M. (2017). Effects of dietary supplementation of zinc oxide nanoparticles on some biochemical biomarkers in common carp (Cyprinus carpio). International Journal of Aquatic Biology, 5(5), 286-294.
Yang, D., Zhang, M., Gan, Y., Yang, S., Wang, J., Yu, M. et al. (2020). Involvement of oxidative stress in ZnO NPs-induced apoptosis and autophagy of mouse GC-1 spg cells. Ecotoxicology and Environmental Safety, 202, 110960.
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008). Nanoparticles in medicine: therapeutic applications and developments. Clinical pharmacology & therapeutics, 83(5), 761-769.